Spyre Therapeutics, Inc. (SYRE) News
Track canonical SquawkNews coverage tagged to SYRE, Spyre Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 12 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
SYRE - Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
SYRE - Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 04, 2026, 08:02 PM UTC
L
Spyre Therapeutics just downgraded at Wolfe Research, here's why
Spyre Therapeutics just downgraded at Wolfe Research, here's why
EQUITY | Jul 28, 2026, 12:26 PM UTC
L
SYRE downgraded from Outperform to Peer Perform @ Wolfe
SYRE downgraded from Outperform to Peer Perform @ Wolfe
EQUITY | Jul 28, 2026, 12:25 PM UTC
L
Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD
Top Downgrades: ACI: NEUTRAL @ UBS CAPR: NEUTRAL @ ROTH CAT: HOLD @ Erste CLX: HOLD @ Jefferies EBC: EQUAL WEIGHT @ Stephens INTU: HOLD @ TD Cowen LAUR: UNDERWEIGHT @ MS LEVI: EQUAL WEIGHT @ WFC MPLT: EQUAL WEIGHT @ MS P
EQUITY | Jul 28, 2026, 11:11 AM UTC
M
SYRE Drops 12%
Spyre Therapeutics stock plunges over 12% on Wednesday due to large insider stock sales
EQUITY | Jun 24, 2026, 03:56 PM UTC
H
HTZ: -21% on Notes Offering
Hertz Global Holdings is down 21% premarket on a proposed offering of $300 million of exchangeable senior first-lien secured PIK notes and $100 million of common stock
EQUITY | Jun 24, 2026, 01:13 PM UTC
H
HTZ: -17% on Notes Offering
Hertz Global Holdings is down 17% premarket on a proposed offering of $300 million of exchangeable senior first-lien secured PIK notes and $100 million of common stock
EQUITY | Jun 24, 2026, 12:22 PM UTC
M
Healthcare Stocks Move
Multiple healthcare stocks are moving in Tuesday's after-market session, with some rising and others falling
EQUITY | Jun 23, 2026, 09:09 PM UTC
H
DFTX +65% on Phase 3 Results
DFTX shares rise 65% on positive topline results from Phase 3 Emerge Study of DT120
EQUITY | Jun 22, 2026, 01:17 PM UTC
H
APGE +45% on Acquisition
AbbVie to acquire Apogee Therapeutics, sending APGE stock up 45% premarket
EQUITY | Jun 22, 2026, 12:21 PM UTC
H
SAGT Surges 76%
Sagtec Global shares rise 75.6% in pre-market trading after issuing financial year 2026 guidance projecting 35% revenue growth
EQUITY | Jun 22, 2026, 09:23 AM UTC